Skip to main content
. 2020 Sep 15;68(2):204–213. doi: 10.1007/s12630-020-01816-z

Table 5.

Characteristics and outcomes of patient subgroups

Variable Group A Group B Group C
Definition Consent to IMV, Consent to IMV, Decline IMV,
IMV not used IMV used IMV not used
n 19 43 13
Age 56 [46–67] 60 [54–67] 81 [70–83]
No medical history 6 (32) 5 (12) 0
Hypertension 8 (42) 30 (70) 12 (92)
Diabetes mellitus 6 (32) 15 (35) 6 (50)
Lymphopenia (<1.0·109·L−1) 14 (78) 32 (74) 12 (92)
Ferritin (g·L−1) 787 [371–2364] 1406 [420–1681] 1562 [482–2929]
CRP (mg·L−1) 177 [151–193] 123 [62–236] 114 [79–165]
D-dimers (ng·mL−1) 1125 [873–2151] 1088 [599–2329] 2273 [1632–3060]
Day 1 SOFA score 2 [0–4] 6 [5–7] 8 [4–8]
VTE 2 (11) 12 (28) 0
VFDs 28 [28–28] 11 [0–22] 6 [2–28]
ICU LOS (days) 3.7 [3.0–7.8] 12.5 [9.8–28.2] 3.9 [2.0–10.1]
ICU mortality 0 (0) 8 (19) 9 (69)
Hospital mortality 1 (5) 9 (21) 9 (69)

Data presented as n (%) or median [interquartile range]

CRP = C-reactive protein; ICU = intensive care unit; IMV = invasive mechanical ventilation; LOS = length of stay; SOFA = sequential organ failure assessment; VFDs = ventilator-free days; VTE = venous thromboembolism